Navigation Links
Hematogenix Launches Comprehensive Molecular Profiling Test iDNAfyTM
Date:7/17/2014

TINLEY PARK, Ill., July 17, 2014 /PRNewswire-iReach/ -- Hematogenix Laboratory Services (Hematogenix), a leader in integrated pathology services for drug development and personalized diagnostics, today announced the launch of its comprehensive molecular profiling service, iDNAfyTM.  Available through the company's Pharma and Diagnostic Service arms, the service provides Oncology clients with actionable information to optimize targeted cancer therapy for their patients.

iDNAfyTM brings a holistic approach to guided therapies by screening and confirming high-relevance somatic mutations.  The targeted identification of these mutations in tumor suppressors and key oncogenes will provide crucial information for the oncologist to use as a guide when deciding on the appropriate therapies and personalized cancer treatments for their patients.  

"Physicians are able to personalize treatments for their patients like never before using the molecular profiles of cancer tissue samples, and we are delighted to introduce a service that adds such value to the process," said Dr. Hytham Al‐Masri, CEO and President of Hematogenix.  "IDNAfyTM will provide an efficient and cost effective approach to identifying genetic mutations that help connect patients' tumors with the appropriate drug of choice by their physician, and our report will assist in matching them with innovative clinical trials." 

Hematogenix has incorporated Agena Bioscience's MassARRAY® system into its existing technologies to support the launch of its Tumor Profiling Services, which complements existing platforms with a more comprehensive testing menu.

"Physicians have the benefit of working with our Pathologists to choose from existing technologies such as IHC, FISH/ISH, and PCR to personalize testing in our full service oncology laboratory," said Dr. Al-Masri.  "Today, results of molecular profiling can contraindicate chemotherapy altogether in favor of other therapies, and iDNAfyTM is a critical aid to this process."

About Hematogenix
Hematogenix is a CAP, CLIA (Clinical Laboratory Improvement Amendments) certified laboratory with a full complement of board certified clinical, anatomic and research pathologists to provide consultation and guidance for all aspects of their pharma and diagnostic services. The company offers a comprehensive array of biomarker development and testing services designed to navigate the complexities of human subject clinical trials. Hematogenix provides logistic management of tissue and sample procurement, distributes collection kits and contributes to standards and procedures required for initiating a clinical trial. Powered by a state‐of‐the‐art laboratory information system, Hematogenix facilities and practices comply with rigorous chain of custody and specimen management practices. Learn more about Hematogenix biomarker and diagnostic services at www.hematogenix.com.

Media Contact: Kathryn Evans, Hematogenix, 708-444-0444, kevans@hematogenix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Hematogenix
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery
2. ReachMD Launches New Oncology Show Featuring Well-known Cancer Expert and Host, Selma Schimmel
3. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
4. HealthEconomics.Com Launches Live Streaming Educational Series in HE-Xpo®, the Pharma Industry’s Only Online Virtual Community for Health Economics and Outcomes Research
5. The Houston Methodist Human Performance Lab Launches Innovative Study on Triathletes, Investigating the Effects of Aging and Training Variables on Triathlon Performance
6. Shire Launches Online Educational Resource Center for US Patients with Ulcerative Colitis
7. Finesse Solutions Launches Next Generation G3Pro Universal SmartControllers to Enhance Productivity in Pilot and Production Scale Cell Culture
8. Foundation for the NIH Launches Bone Quality Project
9. Applied Silicone Launches Ultra-Soft LSR
10. Deadline Solutions, Inc. Launches Amazon Store with the WVS ® Branded LogTag® Temperature Data Recorder
11. The Conferences Forum Launches Patients as Partners Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):